Conclusions Disease stabilization is reported in some patients with several targeted treatments and might be beneficial in subgroups of patients or in combination with classic chemotherapy. None of the hitherto explored targeted treatments can currently be recommended as standard treatment in MM. Content Type Journal ArticlePages 1-15DOI 10.1007/s00280-011-1655-3AuthorsJan Nyrop Jakobsen, Department of Oncology, Finsencentre, Copenhagen, DenmarkJens Benn Sørensen, Department of Oncology, Finsencentre, Copenhagen, DenmarkJournal Cancer Chemotherapy and PharmacologyOnline ISSN 1432-0843Print ISSN 0344-5704 (Source: Cancer Chemotherapy and Pharmacology)
No comments:
Post a Comment